Trevena Inc

General ticker "TRVN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.4M

Trevena Inc does not follow the US Stock Market performance with the rate: -40.1%.

Estimated limits based on current volatility of 6.6%: low 1.58$, high 1.80$

Factors to consider:

  • Current price 83.7% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [9.64$, 27.63$]
  • 2024-12-30 to 2025-12-30 estimated range: [7.44$, 20.68$]

Financial Metrics affecting the TRVN estimates:

  • Negative: Non-GAAP EPS, $ of -52.81 <= 0.10
  • Negative: Operating profit margin, % of -91.86 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -74.24 <= 2.35
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85

Similar symbols

Short-term TRVN quotes

Long-term TRVN plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.57MM $0.00MM $3.12MM
Operating Expenses $52.49MM $56.38MM $38.41MM
Operating Income $-51.92MM $-56.38MM $-35.29MM
Non-Operating Income $0.34MM $2.71MM $-4.68MM
Interest Expense $0.00MM $1.26MM $0.00MM
R&D Expense $13.43MM $18.21MM $16.33MM
Income(Loss) $-51.59MM $-53.67MM $-39.97MM
Taxes $0.00MM $0.00MM $0.32MM
Profit(Loss) $-51.59MM $-53.67MM $-40.29MM
Stockholders Equity $64.63MM $15.60MM $-7.66MM
Inventory $2.35MM $0.91MM $0.00MM
Assets $80.12MM $48.68MM $40.60MM
Operating Cash Flow $-50.20MM $-51.48MM $-33.03MM
Capital expenditure $0.02MM $0.03MM $0.04MM
Investing Cash Flow $-0.02MM $0.02MM $-0.04MM
Financing Cash Flow $7.73MM $23.50MM $26.31MM
Earnings Per Share* $-7.82 $-14.88 $-54.51

* EPS are Split Adjusted, recent splits may be reflected with a delay.